personnel to support its expansion such as Cardiac Medicine department and Opthalmology department. Selling Expenses For the 6-month periods of 2015 and 2016 , the Company and its subsidiary incurred selling
แบบ profit sharing ตามหลักศาสนาอิสลาม ความเสี่ยงด้านสภาพตลาดของศุกูกที่อาจมีตราสารให้เลือกลงทุนและสภาพคล่องน้อยกว่าตลาดตราสารหนี้ทั่วไป เป็นต้น support rating หมายถึง rating ที่สถาบันจัดอันดับความน่า
Operating results of the Company for the three-month period ended 31 March 2019 and 2018 are as follows: Revenue by segment Revenue Cost Gross Profit For three-month period ended 31 March For three-month
-month period net profit criteria consideration based on the latest reviewed consolidated financial statement ended March 31, 2020 which equals to 32.52% and is therefore considered as Class 2 transaction
sector’s growth slowed down and private investment slightly dropped. However, private consumption continued to hold up, partly due to improvements in non-farm income and government measures to support low
(%) Net Profit 59.33% 50.68% 47.12% 47.35% 44.88% Information Memorandum on Acquisition of Assets O.C.C. Public Company Limited หน้า 12 จาก 20 Part 3 Financial Information Financial Status and Performance
, Structural Improvements, Enhanced Portfolio, New Investment Strategy In 2018: Revenue $10.7 billion, +27% YoY Core EBITDA of $1.4 billion, +44% YoY, Core EBITDA margin 13% Net Profit (after Tax/NCI) of
up capital 1,160,000 1,160,000 1,160,000 Shareholders’ equity -533,837 -637,109 2,267,549 Total revenue 199,916 657,968 1,626,871 Total costs 235,424 866,349 1,700,918 Profit before taxation 101,739
604.68 29.78 Net profit 104.39 5.47 Remark: * Audited Financial Statements ended as at December 31,2017 which is audited by At-Ze’s auditor. ** Based on Share Sale and Purchase Agreement , the At-Ze’s ex
gross profit margin and long-term shareholders’ equity. (4) Low cost source of funds on loan from financial institution upon the Company’s capital base is adequate for loan support due to interest rate is